ENDRA Life Sciences (NDRA) Revenue (2016 - 2018)

ENDRA Life Sciences (NDRA) has reported Revenue for 3 consecutive years, with $6174.0 the latest figure, recorded in Q1 2018.

• On a quarterly basis, Revenue changed N/A year-over-year to $6174.0 in Q1 2018; TTM through Dec 2018 was $6174.0, a 98.24% decrease from a year earlier, with the FY2018 full-year figure at $6174.0, down 98.24% from the prior year.
• Revenue was $6174.0 for Q1 2018 at ENDRA Life Sciences, down from $6850.0 in the prior quarter.
• Over five years, Revenue peaked at $515582.0 in Q4 2016 and troughed at $6174.0 in Q1 2018.
• A 3-year average of $174675.6 and a median of $57772.0 in 2017 frame the typical range for Revenue.
• The widest YoY moves for Revenue: up 98.67% in 2017, down 98.67% in 2017.
• Over 3 years, Revenue stood at $515582.0 in 2016, then slumped by 98.67% to $6850.0 in 2017, then retreated by 9.87% to $6174.0 in 2018.
• The last three Revenue figures came in at $6174.0 (Q1 2018), $6850.0 (Q4 2017), and $287000.0 (Q3 2017), per Business Quant data.